| Budget Amount *help |
¥42,770,000 (Direct Cost: ¥32,900,000、Indirect Cost: ¥9,870,000)
Fiscal Year 2018: ¥10,400,000 (Direct Cost: ¥8,000,000、Indirect Cost: ¥2,400,000)
Fiscal Year 2017: ¥10,400,000 (Direct Cost: ¥8,000,000、Indirect Cost: ¥2,400,000)
Fiscal Year 2016: ¥10,400,000 (Direct Cost: ¥8,000,000、Indirect Cost: ¥2,400,000)
Fiscal Year 2015: ¥11,570,000 (Direct Cost: ¥8,900,000、Indirect Cost: ¥2,670,000)
|
|---|
| Outline of Final Research Achievements |
In this study, we aimed to understand molecular mechanisms of malignant property in aspect of stem cell regulation by nutrient signals. As a result, firstly, we found that activation of mTOR complex 1 induces upregulation of glycolysis and mitochondrial activity and contributes to good balance between energy consumption and production for tumor progression. Secondly, we revealed that combining a Ca2+ mobilizer with the autophagy inhibitor remarkably suppress tumor growth in vitro and in vivo, proposing new therapeutics for GBM patients. Thirdly, we discovered an important tumor suppressive mechanism in hematopoietic stem cells against the ill effects caused by the dysbiosis (microbial imbalance) of gut microbiota induced by a high fat diet.
|
